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Alterations in dopaminergic system have
been implicated in the pathophysiology of
this disease for many years, and this study
wasperformed toassess thepossible involve-
ment of the dopamine D4 receptor (DRD4)
gene polymorphisms either in the 50 upstre-
am or in the coding regions, in the etiology
of schizophrenia. The approach included
an association study with 90 Portuguese
trios by doing the analysis of the individual
alleles and the haplotypes. For the polymor-
phisms in the 50 upstream region (C616G
and C521T) and in the coding region (48 bp
repeat) of the DRD4 gene, negative results
were obtained with both haplotype rela-
tive risk (HRR) and transmission disequili-
brium test (TDT), as well as transmit. These
data suggest that polymorphisms (C616G,
C521T, and 48 bp repeat) at the DRD4 gene
do not have a minor effect in the suscept-
ibility to schizophrenia in our sample.
 2003 Wiley-Liss, Inc.
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INTRODUCTION
Schizophrenia is a clinically heterogeneous disease
involving genetic and environmental factors. Despite
extensive research efforts, no mutations, or disease pre-
disposing DNA sequence variations, have been identi-
fied, and the molecular basis of genetics remain elusive.
Although several linkage studies have been performed
to localize major effect susceptibility genes for schizo-
phrenia [Riley and McGuffin, 2000; Baron, 2001],
association studies are also relevant, since the genetic
etiology may be multifactorial or polygenic. Therefore,
any single susceptibility gene contributes only a small
fraction to the overall risk, and allelic variation at such
genes must be high, and can be directly evaluated as
susceptibility factors using candidate gene association
studies [Risch and Merikangas, 1996]. Indeed, linkage
disequilibrium mapping is a powerful alternative to
linkage analysis for the mapping and detection of genes
involved in schizophrenia with a modest effect [Lander,
1996; Risch and Merikangas, 1996; Collins et al., 1997;
Ott and Hoh, 2000].
Disturbances in dopamine neurotransmission and
dopamine receptors have long been suggested to play
a crucial role in the pathogenesis of schizophrenia
[Prasad et al., 2002]. To date, five distinct subtypes of G
protein coupled dopamine receptorsmediate the actions
of dopamine (DRD1, DRD2, DRD3 DRD4, and DRD5)
(for review see Missale et al., 1998). The gene which
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codes for dopamine receptor D4 (DRD4) is considered
as one of the most relevant candidate genes of schizo-
phrenia because it is expressed in limbic system and
clozapine, theprototype of atypical antipsychotics, binds
to DRD4with an affinity ten times higher than to DRD2
and DRD3 receptors [Van Tol et al., 1991]. In addition,
DRD4 gene shows a unique high degree of variation in
the human population [Van Tol et al., 1992], with
several polymorphisms located both in translated and
non-translated regions [Van Tol et al., 1992; Lichter
et al., 1993; Petronis et al., 1994; Paterson et al., 1996],
with a particular relevance for variants in the 50 up-
upstream region [Seaman et al., 1999; Barr et al., 2001].
Although several polymorphisms have been described
in the DRD4 gene, the most widely studied in schizo-
phrenia,was the polymorphism48 bp repeat localized in
the third exon [Lichter et al., 1993], with conflicting
results, potentially because of the differences of meth-
odology [Barr et al., 1993; Kennedy et al., 1993; Sommer
et al., 1993; Macciardi et al., 1994; Shaikh et al., 1994;
Petronis et al., 1995; Skaikh et al., 1995; Tanaka et al.,
1995; Paterson et al., 1996; Serretti et al., 2001]. To solve
these conflicting results, more independent association
studies are required, using a homogeneous population,
as for example the Portuguese population [Schindler
et al., 1999]. In small homogeneous populations, the
genetic variability can be reduced and the environmen-
tal and cultural variabilities are, likewise, lower than
cosmopolitan population. These factors should increase
the chances of detecting at least some possible genetic
loci. Our group has been studying the genetics of psy-
chotic disorders in a sample with reduced heterogeneity
derived from mainland Portugal and Azores, Portugal.
The Azores are a nine-island archipelago in the Atlantic
settled exclusively by the Portuguese in the early 1400s.
The familial transmission has been consistent and well
documented for at least 300 years. The average number
of families with the same last name is a good marker
for the degree of homogeneity. Surname analysis of
the population showed a 79-fold reduction in vari-
ability in surnames for the Azorean population and a
55-fold reduction in surnames for the Continental
Portuguese population, in comparison to United States
population [Schindler et al., 1999]. Furthermore, it is
important to investigate polymorphisms in the 50
upstream region, because variations in the regulation
of the gene could bemore important than any structural
changes in the protein. Thus, the aim of the present
study was to investigate the possible involvement of
several polymorphisms of theDRD4 gene in the etiology
of schizophrenia, particularly C616G and C521T
polymorphisms in the region 50, at the start site of
transcription, and the48bp repeatpolymorphism, in the
coding region.
MATERIALS AND METHODS
Patient Sample
For this study, the sample consists of 90 unrelated
schizophrenic patients from Azores and Mainland,
Portugal (58 males and 32 females) and their parents,
atotalof270individuals.Approvalwasobtainedfromlocal
ethics committees and informed consent was taken from
all subjects. All patients were personally interviewed
using the Diagnostic Interview for Genetics Studies
(DIGS), rated with the Operational Criteria checklist
OPCRIT, and all were diagnosed according toDSM-IV.
Genetic Analysis
High-molecular weight genomic DNA was extracted
from peripheral blood leukocytes according to the
standard method described by Miller et al. [1988], with
slight modifications.
Three polymorphisms in the DRD4 gene were inves-
tigated, two in the 50 upstream region (C616G and
C521T) and one in the coding region (48 bp repeat).
PCR amplification of the polymorphisms (C616G and
C521T) of the DRD4 gene was achieved as described
by Barr et al. [2001]. Briefly, PCR amplification was
carried out in a final volume 20 ml, with the PCRx
enhancer system (1 PCR amplification buffer, 1
PCRx enhancer solution), 100 ng genomic DNA tem-
plate, 200 mM dNTPs, 5 ng/ml of each primer, 1.5 mM
MgCl2, and 0.5 U of Taq polymerase (Perkin Elmer,
Toronto, Canada). After an initial denaturation step at
948C for 4 min, there were 35 cycles, each consisting of
948C for 40 sec, 588C for 40 sec, and 728C for 40 sec. PCR
products (7 ml for each polymorphism) were digested
using either enzyme AvaII or BssHI, and the digested
fragments were separated in 2.0 and 2.5% agarose gel,
respectively, and were visualized by ethidium bromide
staining.
The 48 bp repeat polymorphism localized in third
exon of DRD4 gene was detected by PCR according
to the method descrobed by Lichter et al. [1993]. The
PCR was carried out in a total volume of 25 ml contain-
ing 200 ng genomic DNA as template, 200 mM (dATP,
dTTP, dCTP), 100 mM dGTP, 100mM deaza-dGTP,
1.0 mM of each primer, 10 mM Tris-HCl (pH¼ 8.3),
1.0 mMMgCl2, 10% DMSO, and 1 U of Taq polymerase
(Perkin-Elmer). PCR amplification is initiated at 958C
for 5 min and performed for 40 cycles of 958C for 20 sec,
548C for 20 sec, and 728C for 40 sec. Fragments were
separated in 3.5% agarose gel and visualized by
ethidium bromide.
Statistical Analysis
Statistical analysis was performed using the haplo-
type relative risk (HRR) [Terwilliger and Ott, 1992],
and transmission disequilibrium test (TDT) [Spielman
et al., 1993; SpielmanandEwens, 1998]which avoid any
potential population stratification. We used the HRR
and TDT to test if themarker locus and the hypothetical
disease locus were linked or in linkage disequilibrium.
The TDT–STDT programe (v 1.1) uses data from heter-
ozygous parents only, and test for individual markers.
Furthermore, multiple marker haplotype transmis-
sion was performed with program TRANSMIT v 2.5
[Clayton, 1999]. The program TRANSMIT tests for
association between markers and disease, examining
the transmission of multilocus haplotypes.
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RESULTS
We have performed an association study with 90
trios and C616G and C521T polymorphisms in the
upstreamregion, aswell as a48bp repeat polymorphism
in the coding region in the DRD4 gene. Tables I and II
show the results of HRR and TDT analysis for the
C616G and C521T polymorphisms in the DRD4
gene. Using the HRR and TDT methods, no significant
differences were observed between transmitted and not
transmitted alleles for both polymorphisms in the 50
upstream region (C616G polymorphism w2¼0.047,
df¼1, P¼0.828; C521T polymorphism w2¼0.545,
df¼1, P¼ 0.461). Concerning 48 bp repeat polymorph-
ism of the DRD4 gene the allele frequencies were four
repeats >7 repeat >2 repeats> rare alleles. Similarly,
HRR and TDT analysis yielded non-significant P values
for association of 48 bp repeat polymorphism at the
DRD4 gene with schizophrenia (w2¼ 0.108, df¼3,
P¼1.000; Table III). Furthermore, we tested the trans-
mission of alleles from C616G, C521T, and 48 bp
repeat polymorphisms as a haplotype usingTRANSMIT
and the results are shown in Table IV. The analysis of
multiple marker haplotypes provided no evidence for
association with schizophrenia at this locus. Also, we
estimated the haplotype frequencies of three markers
in the DRD4 gene, and a total of 16 haplotypes were
detected, but Table IV presents the haplotypes with a
frequency above 3% only.
DISCUSSION
Schizophrenia is one of the most extensively studied
brain disorders in molecular genetic studies, and
primordial attention was given to dopaminergic system
in the etiology of this disorder, with special focus on
the dopamine D2-like (DRD2, DRD3, DRD4) receptor
subtype genes, with inconclusive results. In complex
disorders, like schizophrenia, which result from various
vulnerability genes, family association studies are the
most appropriate approaches to explore the putative
contribution at candidate gene loci [Ott and Hoh, 2000].
Several factors could complicate the molecular genetics
of schizophrenia including genetic heterogeneity. In
order to avoid this factor, it is extremely crucial to study
homogenous populations, as for example thePortuguese
population. Whereas most studies have investigated
only the 48 bp repeat in the third exon, which alters the
third intercytoplasmic loop, it is important to investi-
gate polymorphisms in the 50 upstream region, because
variations in the regulation of the gene could be more
important than any structural changes in the protein.
Thus, in this study we investigated two polymorphisms
in the 50 upstream region (C616G and C521T) and
one polymorphism in the coding region (48 bp repeat)
at DRD4 gene for susceptibility to schizophrenia in the
Portuguese population by using family-based associa-
tion analysis. In the present study, using a dual genetic
approach of association analysis, HRR and TDT, no
evidence for association or linkage disequilibrium was
found for the individual alleles or the haplotypes of the
polymorphisms C616G, C521T, and 48 bp repeat, of
the DRD4 gene and schizophrenia. The results of this
study indicate that, in our sample, the C616G and
C521T polymorphisms are not directly involved in
the pathogenesis of schizophrenia, and are in agre-
ement with an association study that found no associa-
tion between both polymorphisms and schizophrenia
[Mitsuyasu et al., 2001]. Concerning the 48 bp repeat
polymorphism of theDRD4 gene, our finding is different
from previous case-controls association study in the
TABLE I. HRR and TDT Results for (C616G) Polymorphism of
DRD4 Gene in Portuguese Schizophrenic Trios
DRD4 gene
Transmitted
Not
transmitted w2 (df¼ 1), P value
HRR C616 113 110 w2¼0.047, P¼ 0.828
G616 67 70
TDT C616 54 49 w2¼0.243, P¼ 0.622
G616 49 54
TABLE II. HRR and TDT Results for (C521T) Polymorphism of
DRD4 Gene in Portuguese Schizophrenic Trios
DRD4 gene
Transmitted
Not
transmitted w2 (df¼1), P value
HRR C521 85 93 w2¼ 0.545, P¼ 0.461
T521 95 87
TDT C521 57 63 w2¼ 0.300, P¼ 0.584
T521 63 57
TABLE III. HRR and TDT Results for 48 bp Repeat Polymorphism of DRD4 Gene in Portuguese
Schizophrenic Trios
DRD4 gene
Transmitted Not transmitted w2 (df¼3), P value
HRR 2 Repeat 23 21 w2¼0.108, P¼1.000
4 Repeat 115 117
7 Repeat 39 39
Others 3 3
TDT 2 Repeat 18 15 w2¼0.273, P¼0.642
4 Repeat 46 48 w2¼0.043, P¼0.836
7 Repeat 34 35 w2¼0.014, P¼0.906
Others 2 2 w2¼1.000, P¼0.317
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Portuguese population [Valente et al., 1997], as well as
in another population [Okuyama et al., 1999], where a
positive association between DRD4 gene and schizo-
phrenia was found. The failure of our study to replicate
the positive association between the 48 bp repeat poly-
morphism and schizophrenia in a Portuguese popula-
tionmayhavebeendue to a stratification effect, and that
positive association might have been due to a chance
positive finding. However, our results are in agreement
with other association studies that found no association
between the DRD4 gene and schizophrenia [Sommer
et al., 1993; Petronis et al., 1995; Skaikh et al., 1995;
Tanaka et al., 1995; Paterson et al., 1996; Serretti et al.,
2001], and also in accordance with family association
and linkage studies that found no association and no
linkage between schizophrenia and DRD4 [Barr et al.,
1993; Kennedy et al., 1993; Macciardi et al., 1994;
Shaikh et al., 1994].
Despite these results, the dopamine system remains
an important area of investigation in schizophrenia.
Indeed, the identification of genes that contribute to the
susceptibility to schizophrenia has been disappointing
using traditional genetic approaches.Further directions
to identify the susceptibility genes include the use of
larger samples in order to increase the statistical power,
the development of more powerful statistical analysis
applying a best definition of the clinical phenotype of
the disease by using endophenotypes, and performing
advanced molecular genetic techniques [Ott and Hoh,
2000; Baron, 2001; Cornblatt and Malhotra, 2001;
Gordon et al., 2001; Hoh and Ott, 2001; Hoh et al.,
2001; Majewski et al., 2001; Tsuang, 2001].
In summary, using two different association meth-
odologies (HRR and TDT) as well as TRANSMIT both
studies were unable to demonstrate a minor effect of
the DRD4 gene in the predisposition to schizophrenia
in our family data. The clinical manifestations of schi-
zophrenia suggest a disease produced by a variable
mixture of genetic predispositions. Therefore, we may
conclude that dopamine hypothesis of schizophrenia by
its own is clearly insufficient to explain many biological
factors underling this disorder, and the involvement of
dopamine in schizophrenia together with other neuro-
transmitter changes is more crucial.
REFERENCES
Baron M. 2001. Genetics of schizophrenia and the new millennium:
Progress and pitfalls. Am J Hum Genet 68:299–312.
Barr CL, Kennedy JL, Lichter JB, Van Tol HHM, Wetterberg L, Livak K,
Kidd KK. 1993. Alleles at the dopamine D4 receptor locus do not
contribute to the genetic susceptibility to schizophrenia in a large
Swedish kindred. Am J Med Genet 48:218–222.
Barr CL, Feng Y, Wigg KG, Schachar R, Tannock R, Roberts W, Malone M,
Kennedy JL. 2001. 50-Untranslated region of the dopamine D4 receptor
gene and attention-deficit hyperactivity disorder. Am J Med Genet
105:84–90.
Clayton D. 1999. A generalization of the transmission/disequilibrium test
for uncertain-haplotype transmission. Am J Hum Genet 65:1170–
1177.
Collins FS, Guyer MS, Chakravati A. 1997. Variations on a theme: Catalo-
guing human genetic variation. Science 278:1580–1581.
Cornblatt BA, Malhotra AK. 2001. Impaired attention as a endopheno-
type for molecular genetic studies of schizophrenia. Am J Med Genet
105:11–15.
Gordon D, Hoh J, Finch SJ, Levenstien MA, Edington J, Li W, Majewski J,
Ott J. 2001. Two approaches for consolidating results from genome
scans of complex traits: Selection methods and scan statistics. Genet
Epidemiol 21:S396–S402.
Hoh J, Ott J. 2001. A train of thoughts on gene mapping. Theor Popul Biol
60:149–153.
Hoh J, Wille A, Ott J. 2001. Trimming, weighting, and grouping SNPs in
human case-control association studies. Genome Res 11:2115–2119.
Kennedy JL, Van Tol HHM, Petronis A, Sidenberg DG, Macciardi F,
Honer WG, Basset AS. 1993. Dopamine D4 receptor gene variants gene
variants and schizophrenia. Schizophr Res 9:122.
Lander ES. 1996. The new genomics: Global views of biology. Science 274:
1594–1595.
Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ. 1993.
A hypervariable segment in the dopamine receptor D4 (DRD4) gene.
HumMol Genet 6:767–773.
Macciardi F, Verga M, Kennedy JL, Petronis A, Giuseppe B. 1994. An
association study between schizophrenia and the dopamine receptor
genes DRD3 and DRD4 using the haplotype relative risk. Hum Hered
44:328–336.
Majewski J, Li H, Ott J. 2001. The Ising model in physics and statistical
genetics. Am J Hum Genet 69:853–862.
Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for
extracting DNA fromhuman nucleated cells. Nucleic Acids Res 16:1215.
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine
receptors: From structure to function. Psysiol Rev 78:189–225.
Mitsuyasu H, Hirata N, Sakai Y, Shibata H, Takeda Y, Ninomiya H,
Kawasaki H, Tashiro N, Fukumaki Y. 2001. Association analysis of
polymorphisms in the upstream region of the human dopamine D4
receptor gene (DRD4) with schizophrenia and personality traits. J Hum
Genet 46:26–31.
TABLE IV. Estimated Haplotype Probabilities and Chi Squared Test of Transmission of
Multi-Marker Haplotypes at the DRD4 Gene Using TRANSMIT
DRD4 gene
Haplotypes Observed Expected O-E Frequency Haplotypic P value
2-1-1 6.111 7.295 2.392 0.041 0.444
4-1-1 33.162 33.104 12.840 0.183 0.987
7-1-1 18.399 16.960 5.654 0.094 0.545
4-2-1 18.552 22.300 7.296 0.123 0.165
2-1-2 7.001 6.803 1.859 0.037 0.884
4-1-2 33.526 32.381 13.915 0.179 0.759
7-1-2 10.409 10.259 3.449 0.056 0.935
4-2-2 29.761 28.214 11.661 0.156 0.651
7-2-2 6.532 8.066 2.896 0.044 0.367
Dopamine D4 Receptor Gene and Schizophrenia 23
Okuyama Y, Ishiguro H, Toru M, Arinami T. 1999. A genetic polymor-
phism in the promoter region of DRD4 associated with expression and
schizophrenia. Biochem Biophy Res Commun 258:292–295.
Ott J,HohJ. 2000. Statistical approaches to genemapping.AmJHumGenet
67:289–294.
Paterson AD, Ying DJ, Petronis A, Schoots O, Lieberman J, Van Tol HHM,
Kennedy JL. 1996. APstI restriction fragment length polymorphism the
50 untranslated region of DRD4 is not associated with schizophrenia.
Psychiatr Genet 6:191–193.
Paterson AD, Sunobra GA, Kennedy JL. 1999. Dopamine D4 receptor gene:
Novelty or nonsense. Neuropsychopharmacology 21:3–16.
Petronis A, Van Tol HHM, Kennedy JL. 1994. A SmaI PCR-RFLP in the 50
noncoding region of the human D4 dopamine receptor gene (DRD4).
Hum Hered 44:58–60.
Petronis A, Macciardi F, Athanassiades A, Paterson AD, Verga M,
Meltzer HY, Cola P, Buchanan JA, Van Tol HHM, Kennedy JL. 1995.
Association study between the dopamine D4 receptor gene and
schizophrenia. Am J Med Genet 60:452–455.
Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Telma BK.
2002. Molecular genetics of schizophrenia: Past, present, and future.
J Biosci 27:35–52.
Riley BP, McGuffin P. 2000. Linkage and association studies of schizo-
phrenia. Am J Med Genet 97:23–44.
Risch N, Merikangas K. 1996. The future of the genetic studies of complex
human disease. Science 273:1516–1517.
Schindler K, Torre C, Bauer A, Medeiros H, Carvalho C, Fernandes LF,
Pato MT, Pato CN. 1999. Identification of a highly homogenous
population for genetic study of psychiatric disorders. CNC Spectrums
4(5):22–24.
Seaman MI, Fischer JB, Chang F-M, Kidd KK. 1999. Tandem duplication
polymorphism upstream of the dopamine D4 receptor gene (DRD4).
Am J Med Genet 88:705–709.
Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E. 2001. DDR4 exon 3
variants associatedwithdelusional symptomatology inmajor psychoses:
A study on 2011 affected subjects. Am J Med Genet 105:283–290.
Shaikh S, Gill M, Owen M, Asherson P, McGuffin P, Nanko S, Murray RM,
Collier DA. 1994. Failure to find linkage between functional polymor-
phism in the dopamine D4 receptor gene and schizophrenia. Am J Med
Genet 54:8–11.
Skaikh S, Collier DA, Sham P, Pilowsky L, Sharma T, Lin LK, Crocq MA,
Gill M, Kerwin R. 1995. Analysis of clozapine response and polymor-
phisms of the dopamine D4 receptor gene (DRD4) in schizophrenic
patients. Am J Med Genet 60:541–545.
Sommer SS, Lind TJ, Heston LL, Sobell Jl. 1993. Dopamine D4 receptor
variants in unrelated schizophrenic cases and controls. AmJMedGenet
48:90–93.
Spielman RS, Ewens WJ. 1998. A sibship test for linkage in the presence
of association: The sib transmission/disequilibrium test. Am J Hum
Genet 62:450–458.
Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for
linkage desequilibrium: The insulin gene region and insulin-dependent
diabetes mellitus (IDDM). Am J Hum Genet 52:506–516.
Tanaka T, Igarashi S, Onodera O, Tanaka H, Kameda K, Takahashi K,
Tsuji S, Ihda S. 1995. Lack of association between dopamine D4 receptor
gene and schizophrenia. Am J Med Genet 60:580–582.
Terwilliger JD, Ott J. 1992. A haplotype-based ‘‘haplotype relative risk’’
approach to detecting allelic associations. Hum Hered 42:337–346.
Tsuang MT. 2001. Definitions alternative phenotypes for genetic studies:
What can we learn from studies of schizophrenia? Am J Med Genet
105:8–10.
Valente J,DouradoA,Coelho I,MacedoA,Ambro´sioA,KingN,Kennedy JL,
Azevedo MH, Pato MT, Pato CN. 1997. Association between DRD4
and schizophrenia in a Portuguese population. Psiquiatria Clı´nica
18:55–59.
Van Tol HHM, Bunzow JR, GuanHC, Sunahara RK, Seeman P, Niznik HB,
Civeli O. 1991. Cloning of the gene for a human dopamine D4 receptor
with high affinity for the antipsychotic clozapine. Nature 350:610–614.
VanTolHHM,WuCM,GuanH-C,OharaK, BunzowJR,Civelli O, Kennedy
JL, Seeman P, Niznik HB, Jovanovic V. 1992. Multiple dopamine D4
receptor variants in the human population. Nature 358:149–152.
24 Ambro´sio et al.
